Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus
- PMID: 31416990
- DOI: 10.12809/hkmj197802
Clinical considerations when adding a sodium-glucose co-transporter-2 inhibitor to insulin therapy in patients with diabetes mellitus
Keywords: Consensus; Diabetes mellitus, type 1; Diabetes mellitus, type 2; Insulins; Sodium-glucose transporter 2 inhibitors.
Conflict of interest statement
All authors have declared no conflicts of interest.
Comment in
-
Sodium-glucose co-transporter-2 inhibitors: know the patient and the drugs.Hong Kong Med J. 2019 Aug;25(4):268-270. doi: 10.12809/hkmj195089. Hong Kong Med J. 2019. PMID: 31416989 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical